Belgium Biomaterials in Healthcare Market Analysis Report [2022-30] I Insights10

Belgium Biomaterials in Healthcare Market Analysis

$ 3999

The Belgium Biomaterials in Healthcare Market is expected to witness growth from $344 Mn in 2022 to $927 Mn in 2030 with a CAGR of 13.20% for the forecasted year 2022-2030. The aging populace in Belgium is driving up demand for biomaterials in Belgium Biomaterials in Healthcare market. The market is segmented by type and by application. Some key players in this market include: Trasis, Acertys Healthcare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.

ID: IN10BEMD003 CATEGORY: Medical Devices GEOGRAPHY: Belgium

Buy Now

Belgium Biomaterials in Healthcare Market Executive Analysis

The Belgium Biomaterials in Healthcare Market size is at around $344 Mn in 2022 and is projected to reach $927 Mn in 2030, exhibiting a CAGR of 13.20% during the forecast period. In 2021, Belgium allocated 0.6% of GDP to the administration and security of the public healthcare system. Overall health spending in Belgium has steadily grown over time, going from 10.5% in 2015 to 12.5% in 2020 as a percentage of GDP. The overall funding exceeds the average for the EU. Public (total) spending has gradually grown over the past ten years, generally keeping up with levels in the European Union. (EU).

In Belgium, in order to replace or heal damaged tissue or organs, the body uses biomaterials, which can be synthetic or natural materials. They are useful and advantageous in the area of medicine. Skin, bone, and cartilage are just a few of the novel tissues and organs that can be created using biomaterials in tissue engineering. Patients who have diseases or injuries that call for tissue replacement may benefit from this particularly. To transport medications to particular body parts, biomaterials can be used as drug delivery systems. By doing so, the medications' potency may be increased and their side effects may be diminished. Dental implants, which change missing teeth or support dentures, frequently use biomaterials. This can enhance the patient's ability to chew and talk, as well as their general quality of life. Because they are intended to be biocompatible, biomaterials do not damage the body or elicit an immune reaction. They are therefore a secure and useful choice for medical purposes. In order to replace or heal damaged tissue in the heart and blood vessels, biomaterials are also used in cardiovascular devices like stents and heart valves.

Market Dynamics

Market Growth Drivers

The Belgian government is promoting the use of biomaterials in the healthcare industry through a number of projects. For instance, the government has started a number of initiatives to promote biomaterials and medical device research and development. The aging populace in Belgium is driving up demand for medical services and equipment. Medical implants, which are highly sought-after by the aged, are increasingly being made with biomaterials in the healthcare industry. Biomaterials are becoming more efficient, effective, and secure thanks to technological developments, which is driving up demand for them in the healthcare industry. The demand for these materials in the healthcare industry is also being fueled by the increasing understanding of the advantages of biomaterials among patients and healthcare professionals. Strong industrial capabilities in Belgium allow for the production of premium biomaterials at cost-effective rates. The Belgian healthcare industry for biomaterials is benefiting from this by drawing manufacturers and investors.

Market Restraints

In Belgium, the adoption of biomaterials in the healthcare industry may be constrained by the fact that they can be costly to make and use. This is especially true for some of the more expensive to create and produce advanced biomaterials. Although there is an increasing understanding of biomaterials in the healthcare industry, some patients and healthcare providers still do not. This may restrict the use of biomaterials and hinder the expansion of the industry.

Competitive Landscape

Key Players

Trasis (BE)
Acertys Healthcare (BE)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Healthcare Policies and Regulatory Landscape

Belgium has a firm commitment to the use of cutting-edge medical technologies, such as biomaterials, in its well-developed healthcare system. The Federal Agency for Medicines and Health goods (FAMHP), which is in charge of the authorization, registration, and surveillance of biomaterials, oversees the nation's regulatory framework for biomaterials. Biomaterials are governed as medical instruments and are subject to the FAMHP's specifications. Manufacturers are required to acquire the CE marking, which certifies that the product satisfies the EU's performance and safety standards. Before being sold in Belgium, biomaterials must additionally go through clinical trials to show their safety and efficacy. In terms of healthcare regulations, the Belgian government has put in place regulations to promote the use of nanomaterials in healthcare. For instance, the government has created a national biomaterials platform to promote interaction between business, academics, and healthcare providers. The platform's goal is to hasten the advancement and utilization of nanomaterials in healthcare.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Belgium market in 2019. The growing geriatric population Belgiumly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.